NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-MD-19-013 from the NIH Guide for Grants and Contracts
Notice NOT-DA-19-016 from the NIH Guide for Grants and Contracts
Notice NOT-EY-19-007 from the NIH Guide for Grants and Contracts
Notice NOT-MD-19-014 from the NIH Guide for Grants and Contracts
Notice NOT-MD-19-011 from the NIH Guide for Grants and Contracts
Notice NOT-MD-19-010 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AT-19-009 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Center for Complementary and Integrative Health (NCCIH) solicits grant research applications to study minor cannabinoids and terpenes in the cannabis plant as it relates to pain and nociception. Minor cannabinoids are defined as any and all cannabinoids from the cannabis plant other than ?9-tetrahydrocannabinol (?9-THC). Cannabinoids and terpenes of particular interest include the following: Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol (CBN), Cannabichromene (CBC), Myrcene, ?-caryophyllene, Limonene, ?-terpineol, Linalool, ?-phellandrene, ?-pinene, ?-pinene, ?-terpinene, and ?-humulene. This initiative intends to support highly innovative basic and/or mechanistic studies in appropriate model organisms and/or human subjects aiming to identify, describe and determine whether minor cannabinoids and/or terpenes can help treat pain. The mechanisms and processes underlying potential contribution of minor cannabinoids and terpenes to pain relief and functional restoration in patients with different pain conditions may be very broad. This initiative encourages interdisciplinary collaborations by experts from multiple fieldspharmacologists, chemists, physicists, physiologists, neuroscientists, psychologists, endocrinologists, immunologists, geneticists, behavioral scientists, clinicians, and others in relevant fields of inquiry.
Funding Opportunity RFA-AT-19-008 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Center for Complementary and Integrative Health (NCCIH) solicits grant research applications to study minor cannabinoids and terpenes in the cannabis plant as it relates to pain and nociception. Minor cannabinoids are defined as any and all cannabinoids from the cannabis plant other than ?9-tetrahydrocannabinol (?9-THC). Cannabinoids and terpenes of particular interest include the following: Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol (CBN), Cannabichromene (CBC), Myrcene, ?-caryophyllene, Limonene, ?-terpineol, Linalool, ?-phellandrene, ?-pinene, ?-pinene, ?-terpinene, and ?-humulene. This initiative intends to support highly innovative basic and/or mechanistic studies in appropriate model organisms and/or human subjects aiming to identify, describe and determine whether minor cannabinoids and/or terpenes can help treat pain. The mechanisms and processes underlying potential contribution of minor cannabinoids and terpenes to pain relief and functional restoration in patients with different pain conditions may be very broad. This initiative encourages interdisciplinary collaborations by experts from multiple fieldspharmacologists, chemists, physicists, physiologists, neuroscientists, psychologists, endocrinologists, immunologists, geneticists, behavioral scientists, clinicians, and others in relevant fields of inquiry.
Notice NOT-CA-19-016 from the NIH Guide for Grants and Contracts
Notice NOT-OD-19-051 from the NIH Guide for Grants and Contracts
Notice NOT-AG-18-057 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-CA-19-009 from the NIH Guide for Grants and Contracts. The purpose of the U.S.-China Program for Biomedical Collaborative Research is to stimulate collaborative basic, translational, and clinical research between United States (U.S.)-based researchers and Chinese researchers in the areas of cancer, environmental health, heart disease, blood disorders, diseases of the eye and visual system, mental health, and neurological disorders. Partnering U.S. and Chinese investigators must work jointly to submit identical applications to NIH and National Natural Science Foundation of China (NSFC), respectively. U.S. investigators must respond to the announcement from NIH, including the Chinese application as an attachment, and Chinese investigators must respond to a separate funding announcement from NSFC, including the NIH application as an attachment.
Notice NOT-AG-18-056 from the NIH Guide for Grants and Contracts
Notice NOT-OD-19-050 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DA-19-030 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to develop advanced analytical models, tools and metrics to enhance the decision making and professional evaluation in life sciences management and administration. It is envisioned that the developed tools will be used by the NGOs/disease foundations, advocacy groups, publishing industry, research funders, policy makers and academic institutions.
Funding Opportunity RFA-DA-19-031 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to develop advanced analytical models, tools and metrics to enhance the decision making and professional evaluation in life sciences management and administration. It is envisioned that the developed tools will be used by the NGOs/disease foundations, advocacy groups, publishing industry, research funders, policy makers and academic institutions.
Notice NOT-HD-18-031 from the NIH Guide for Grants and Contracts
Notice NOT-AT-19-012 from the NIH Guide for Grants and Contracts
Notice NOT-NS-19-028 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-19-142 from the NIH Guide for Grants and Contracts. The purpose of the NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) is to support comprehensive and rigorous postdoctoral research and career development experiences in the biomedical, behavioral, or clinical sciences of promising Au.D./Ph.D. audiologists who have the potential to become productive, independent investigators in scientific health-related research fields relevant to NIDCD's mission. This Funding Opportunity Announcement is designed specifically for applicants proposing to lead basic science experimental studies involving humans, referred to in NOT-OD-18-212 as prospective basic science studies involving human participants. These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind. Studies conducted with specific applications toward processes or products in mind should submit under the companion Clinical Trials Required FOA.